[1] González F.Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction[J]. Steroids, 2012, (77): 300-305. [2] Bellver J, Rodríguez-Tabernero L, Robles A, et al.Polycystic ovary syndrome throughout a woman’s life[J]. J Assist Reprod Genet, 2018, 35(1): 25-39. [3] Soares JM, Baracat MC, Maciel GA, et al.Polycystic ovary syndrome: controversies and challenges[J]. Rev Assoc Med Bras, 2015, 61(6): 485-487. [4] Ghowsi M, Khazali H, Sisakhtnezhad S, et al.Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol[J]. Iran J Basic Med, 2018, 21(2): 165-174. [5] Demir İ, Guler A, Alarslan P, et al. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome[J]. Endocrine, 2019, 65(1): 175-183. [6] Puder JJ, Varga S, Kraenzlin M, et al.Central fat excess in polycystic ovary syndrome:relation to low-grade inflammation and insulin resistance[J]. J Clin Endocrinol Metab, 2005, 90(11): 6014-6021. [7] Wolf WM, Wattick RA, Kinkade ON, et al.Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity[J]. Int J Environ Res Public Health, 2018, 15(11): 2589. [8] Rao P, Bhide P.Controversies in the diagnosis of polycystic ovary syndrome[J]. Ther Adv Reprod Health, 2020, 14: 1-11. [9] Kahsar-Miller MD, Nixon C, Boots LR, et al.Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS[J]. Fertil Steril, 2001, 75(1): 53-58. [10] Pan H, Xian P, Yang D, et al.Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression[J]. Endocrine, 2021, 74(3): 518-529. [11] Rees DA, Jenkins-Jones S, Morgan CL.Contemporary reproductive for patients with polycystic ovary syndrome: a retrospective observational study[J]. J Clin Endocrinol Metab, 2016, 101(4): 1664-1672. [12] Li Y, Yao N, Gao Y, et al.MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1[J]. Bioengineered, 2021, 12(1): 8555-8569. [13] Woods JA, Vieira VJ, Keylock KT.Exercise, inflammation, and innate immunity[J]. Immunol Allergy Clin N Am, 2009, 29(2): 381-393. [14] 孙博洋,韩世愈. 慢性低度炎症与多囊卵巢综合征关系的研究进展[J]. 中国优生与遗传杂志,2021,29:1-5. [15] 陈沛林,陈光元,谢家滨,等. 血清炎症因子在多囊卵巢综合征患者中的表达及其临床意义[J]. 海南医学,2016,27(12):1945-1947. [16] İsmail D, Aslı G, Alarslan P, et al.Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome[J]. Endocrine, 2019, 65(1): 175-183. [17] Shao Y, Chang Z, Cheng Y, et al.Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation[J]. Biosci. Rep, 2019, 39(1): 1-14. [18] Ghowsi M, Khazali H, Sisakhtnezhad S.Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol[J]. Iran J Basic Med Sci, 2018, 21(2): 165-174. [19] Blumenfeld Z.The possible practical implication of high CRP levels in PCOS[J]. Clin Med Insights Reprod Health, 2019, 13(1): 1-3. [20] Spazynsky RZ, Arici A, Duleba AJ.Tumor necrosis factor alpha stimulates proliferation of rat ovarian theca-interstitial cells[J]. Biol Reprod, 1999, 61: 993-998. [21] Moshfegh F, Balanejad SZ, Shahrokhabady K, et al.Crocus sativus (saffron) petals extract and its active ingredient, anthocyanin improves ovarian dysfunction, regulation of inflammatory genes and antioxidant factors in testosterone-induced PCOS mice[J]. Journal of Ethnopharmacology, 2022, 282: 114594. [22] 何志伟,胡欣,陈国芳,等. 维生素D 缺乏对女性生殖健康的影响[J]. 医学综述,2022,28(2):321-325. [23] Selimoglu H, Duran C, Kiyici S, et al.The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome[J]. J Endocrinol Invest, 2010, 33(4): 234-238. [24] Rashidi B, Haghollahi F, Shariat M, et al.The effects of calcium vitamin D and metformin on polycystic ovary syndrome: a pilot study[J]. Taiwan J Obstet Gynecol, 2009, 48(2): 142-147. [25] Xu J, Lawson MS, Xu F, et al.Vitamin D3 Regulates Follicular Development and Intrafollicular Vitamin D Biosynthesis and Signaling in the Primate Ovary[J]. Front Physiol, 2018, 9: 1600. [26] 李忆昆. 维生素D对多囊卵巢综合征血清抗缪勒管激素作用的相关研究[D]. 东南大学,2020. [27] Bakhshalizadeh S, Amidi F, Shirazi R, et al.Vitamin D3 regulates steroidogenesis in granulosa cells through AMP-activated protein kinase (AMPK) activation in a mouse model of polycystic ovary syndrome[J]. Cell Biochem Funct, 2018, 36(4): 183-193. |